title: Clinical and laboratory comparison of different brands of amphotericin B used for the treatment of Kala-azar: an observational study.
abstract: The communication presents clinical response of cases of visceral leishmaniasis to treatment by two different brands of Amphotericin B. Fungizone was found to be slightly better than Amphotericin B, however, the difference is not statistically significant.
authors: Rajendra Memorial Research Institute of Medical Sciences, Patna-800007, India. drshyamnarayan@rediffmail.com
authors: Shyam
authors: S
authors: Narayan
authors: A K
authors: AK
authors: Gupta
authors: K
authors: K
authors: Singh Subhankar
authors: C S
authors: CS
authors: Lal
authors: V P
authors: VP
authors: Singh
authors: P K
authors: PK
authors: Sinha
authors: P
authors: P
authors: Das
authors: C P
authors: CP
authors: Thakur
mesh_terms: D000293:Adolescent; D000328:Adult; D000666:Amphotericin B / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D002648:Child; D006801:Humans; D007893:Leishmania donovani / Q000187:drug effects* / Q000302:isolation & purification; D007898:Leishmaniasis, Visceral / Q000188:drug therapy* / Q000469:parasitology / Q000473:pathology; D051379:Mice; D013154:Spleen / Q000187:drug effects / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D000666:Amphotericin B